The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.58, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 58
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.msard.2021.103399
- Dergi Adı: MULTIPLE SCLEROSIS AND RELATED DISORDERS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Anahtar Kelimeler: Neuromyelitis optica spectrum disorders, Myelin oligodendrocyte glycoprotein antibody-associated disorders, Disease modifying treatment, Coronavirus, SARS-CoV-2
- Ondokuz Mayıs Üniversitesi Adresli: Evet
Özet
Background: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are not clearly known.